334 related articles for article (PubMed ID: 26004674)
41. Invasive cervical cancer incidence and mortality among canadian women aged 15 to 29 and the impact of screening.
Popadiuk C; Stankiewicz A; Dickinson J; Pogany L; Miller AB; Onysko J
J Obstet Gynaecol Can; 2012 Dec; 34(12):1167-1176. PubMed ID: 23231799
[TBL] [Abstract][Full Text] [Related]
42. [Analysis of clinical efficacy of intensity-modulated radiation therapy and the prognosis factors in advanced cervical cancer].
Gao K; Ding L; Li L
Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):30-5. PubMed ID: 24694915
[TBL] [Abstract][Full Text] [Related]
43. Stage IIB-IVB cervical adenocarcinoma: prognostic factors and survival.
Lea JS; Sheets EE; Wenham RM; Duska LR; Coleman RL; Miller DS; Schorge JO
Gynecol Oncol; 2002 Jan; 84(1):115-9. PubMed ID: 11748986
[TBL] [Abstract][Full Text] [Related]
44. Influence of stage at diagnosis on survival differences for rectal cancer in three European populations.
Monnet E; Faivre J; Raymond L; Garau I
Br J Cancer; 1999 Oct; 81(3):463-8. PubMed ID: 10507771
[TBL] [Abstract][Full Text] [Related]
45. Prognostic value of histopathology and trends in cervical cancer: a SEER population study.
Vinh-Hung V; Bourgain C; Vlastos G; Cserni G; De Ridder M; Storme G; Vlastos AT
BMC Cancer; 2007 Aug; 7():164. PubMed ID: 17718897
[TBL] [Abstract][Full Text] [Related]
46. A population-based analysis of incidence, mortality, and stage-specific survival of cervical cancer patients in Hong Kong: 1997-2006.
Cheung FY; Mang OW; Law SC
Hong Kong Med J; 2011 Apr; 17(2):89-95. PubMed ID: 21471587
[TBL] [Abstract][Full Text] [Related]
47. Thromboembolic event as a prognostic factor for the survival of patients with stage IIIB cervical cancer.
Renni MJ; Russomano FB; Mathias LF; Koch HA
Int J Gynecol Cancer; 2011 May; 21(4):706-10. PubMed ID: 21546873
[TBL] [Abstract][Full Text] [Related]
48. Screening history and FIGO-stages among Danish women with cervical cancer in 2012-2014: a register-based study.
Bchtawi AK; Saritas S; Schledermann D; Christensen RD; Jochumsen KM
Sci Rep; 2019 Dec; 9(1):20390. PubMed ID: 31892698
[TBL] [Abstract][Full Text] [Related]
49. [Cytological study of 191 women with invasive cancer of the uterine cervix in Brittany, France].
Lavoué V; Gautier C; Piette C; Porée P; Mesbah H; Foucher F; Vialard J; Levêque J
J Gynecol Obstet Biol Reprod (Paris); 2009 Sep; 38(5):396-403. PubMed ID: 19473783
[TBL] [Abstract][Full Text] [Related]
50. Advancing age and cervical cancer screening and prognosis.
Sawaya GF; Sung HY; Kearney KA; Miller M; Kinney W; Hiatt RA; Mandelblatt J
J Am Geriatr Soc; 2001 Nov; 49(11):1499-504. PubMed ID: 11890589
[TBL] [Abstract][Full Text] [Related]
51. The Prognostic Impact of Type 2 Diabetes Mellitus on Early Cervical Cancer in Asia.
Kuo HY; Lin ZZ; Kuo R; Shau WY; Lai CL; Yang YY; Shao YY; Hsu C; Cheng WF; Cheng AL; Yang JC; Lai MS
Oncologist; 2015 Sep; 20(9):1051-7. PubMed ID: 26240133
[TBL] [Abstract][Full Text] [Related]
52. [Evaluation of diagnostic methods and characteristics of patients operated on for cervical cancer in Lithuania, 1998-2000].
el-Aawar B
Medicina (Kaunas); 2002; 38(6):597-610. PubMed ID: 12474666
[TBL] [Abstract][Full Text] [Related]
53. To what extent do age, stage and treatment influence survival after invasive cervical cancer: a French population-based study.
Compaoré ZC; Monnet E; Gérazime A; Molinié F; Guizard AV; Delafosse P; Dabakuyo-Yonli TS; Coureau G; Hammas K; Plouvier S; Bara S; Défossez G; Lapôtre-Ledoux B; Daubisse-Marliac L; d'Almeida T; Launoy G; Mansi L; Trétarre B; Woronoff AS
Cancer Causes Control; 2022 Mar; 33(3):403-415. PubMed ID: 35079925
[TBL] [Abstract][Full Text] [Related]
54. Temporal trends in the relative survival among women with cervical cancer in Canada: a population-based study.
Akhtar-Danesh N; Elit L; Lytwyn A
Int J Gynecol Cancer; 2012 Sep; 22(7):1208-13. PubMed ID: 22854653
[TBL] [Abstract][Full Text] [Related]
55. Real-World Study of the Incidence, Risk Factors, and Prognostic Factors Associated with Bone Metastases in Women with Uterine Cervical Cancer Using Surveillance, Epidemiology, and End Results (SEER) Data Analysis.
Zhang Y; Guo X; Wang G; Ma W; Liu R; Han X; Li L; Baklaushev VP; Bryukhovetskiy AS; Wang W; Wang X; Zhang C
Med Sci Monit; 2018 Sep; 24():6387-6397. PubMed ID: 30207328
[TBL] [Abstract][Full Text] [Related]
56. Cervical cancer in women under 25 years of age in Queensland, Australia: To what extent is the diagnosis made by screening cytology?
Morgan EL; Sanday K; Budd A; Hammond IG; Nicklin J
Aust N Z J Obstet Gynaecol; 2017 Aug; 57(4):469-472. PubMed ID: 28580578
[TBL] [Abstract][Full Text] [Related]
57. Trends in gynecologic cancer among elderly women in Denmark, 1980-2012.
Ør Knudsen A; Schledermann D; Nyvang GB; Mogensen O; Herrstedt J;
Acta Oncol; 2016; 55 Suppl 1():65-73. PubMed ID: 26784001
[TBL] [Abstract][Full Text] [Related]
58. Maternal and fetal outcome after invasive cervical cancer in pregnancy.
Zemlickis D; Lishner M; Degendorfer P; Panzarella T; Sutcliffe SB; Koren G
J Clin Oncol; 1991 Nov; 9(11):1956-61. PubMed ID: 1941053
[TBL] [Abstract][Full Text] [Related]
59. Improved control of invasive cervical cancer in Sweden over six decades by earlier clinical detection and better treatment.
Sparén P; Gustafsson L; Friberg LG; Pontén J; Bergström R; Adami HO
J Clin Oncol; 1995 Mar; 13(3):715-25. PubMed ID: 7884431
[TBL] [Abstract][Full Text] [Related]
60. Understanding cervical cancer after the age of routine screening: Characteristics of cases, treatment, and survival in the United States.
Lichter KE; Levinson K; Hammer A; Lippitt MH; Rositch AF
Gynecol Oncol; 2022 Apr; 165(1):67-74. PubMed ID: 35115179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
